PUVA-induced blisters, complement deposition, and damage to the dermoepidermal junction.

Area of Science:

• Dermatology
• Photobiology
• Immunodermatology

Background:

• Psoralen plus long-wave ultraviolet light (PUVA) therapy is a common dermatological treatment.
• Skin blistering is an uncommon but reported side effect of PUVA therapy.
• The precise mechanism underlying PUVA-induced blistering is not fully understood.

Purpose of the Study:

• To investigate the development and characteristics of skin blistering in patients undergoing PUVA therapy.
• To examine the ultrastructural and immunopathological features of PUVA-induced blisters.
• To assess the prevalence and implications of impaired dermoepidermal adhesion in PUVA-treated patients.

Main Methods:

• Clinical observation of 56 patients undergoing PUVA therapy.
• Histopathological and immunofluorescence analysis of skin biopsy specimens from blistered and non-blistered sites.
• Ultrastructural examination of blister formation and separation planes.
• Measurement of suction blister formation time in 51 patients.

Main Results:

• Seven out of 56 patients developed non-hemorrhagic blisters on clinically normal skin, often associated with friction or trauma.
• Immunofluorescence revealed granular C3 deposits at the dermoepidermal junction and/or around dermal blood vessels in all blistered patients.
• Ultrastructural analysis showed blister separation within the lamina lucida, with impaired dermoepidermal adhesion observed in all PUVA-treated patients.

Conclusions:

• PUVA therapy can lead to impaired dermoepidermal adhesion, manifesting as skin blistering.
• The presence of C3 deposits suggests an immune-mediated component in the blistering process.
• Further research is needed to elucidate the exact mechanism of this dermoepidermal adhesion defect induced by PUVA treatment.